Press Releases

  • Jun. 2019
    LEUKOCARE presenting at the 24th European Hematology Congress in Amsterdam
  • May. 2019
    "Pharma Tech Outlook: Top 10 Drug Discovery&Development Solution Providers in Europe 2019-LEUKOCARE AG"
  • Apr. 2019
    LEUKOCARE to present at multiple European Conferences LEUKOCARE to present at multiple European Conferences
  • Mar. 2019
    LEUKOCARE announces appointment of Dr Andreas Seidl as new Chief Operating Officer and member of the Executive Board
  • Nov. 2018
    LEUKOCARE presenting at the 10th PEGS Summit Europe in Lisbon, Portugal
  • Nov. 2018
    Informa 2018 Survey predicts Drug Product Formulation Recognition and Budgets to increase significantly
  • Oct. 2018
    Rentschler Biopharma and LEUKOCARE to announce findings of recent international Drug Product Formulation Survey at BIO-Europe® 2018
  • Sep. 2018
    LEUKOCARE presenting at 12th Vaccine Congress in Budapest, Hungary
  • Sep. 2018
    LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulations for the development of value-added anti-infective therapies
  • Jun. 2018
    LEUKOCARE grants a license on its SPS® formulation technology platform to Laboratorios Liomont for development and commercialization of a biosimilar